1. Home
  2. PCRX vs EVEX Comparison

PCRX vs EVEX Comparison

Compare PCRX & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.17

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$2.43

Market Cap

888.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
EVEX
Founded
2006
2020
Country
United States
United States
Employees
N/A
198
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
999.0M
888.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
EVEX
Price
$25.17
$2.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$30.25
$6.88
AVG Volume (30 Days)
450.1K
1.2M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.07
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
N/A
Revenue Next Year
$8.54
$11,676.47
P/E Ratio
$364.29
N/A
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$2.32
52 Week High
$27.64
$7.48

Technical Indicators

Market Signals
Indicator
PCRX
EVEX
Relative Strength Index (RSI) 60.53 38.55
Support Level $22.03 $2.33
Resistance Level $27.03 $3.13
Average True Range (ATR) 0.94 0.16
MACD 0.12 -0.00
Stochastic Oscillator 69.42 19.44

Price Performance

Historical Comparison
PCRX
EVEX

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment, a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

Share on Social Networks: